"9% versus 10% reported at least one symptom beyond 4 weeks, and 4% versus 2% at least one symptom beyond 12 weeks"
That's not low for a virus which is infectious as Delta, and it's certainly not "about zero".
That's not low for a virus which is infectious as Delta, and it's certainly not "about zero".
> Although this is pure randomness with such close measurements.
That's not how this works at scale. We need larger studies, yes, but you can't simply dismiss a doubling of long-term symptom reports.
At population scale, even a 1-2% incidence means millions of people.